| 
Connections
Online
Sessions Schedule - November
November
9, 2004, Tuesday
Speaker: Spencer Richlin, M.D., (Reproductive Medicine
Associates of
Connecticut)
Topic: The Medical Work Up for a Woman Experiencing
Difficulty
Conceiving
Time: 8-9 PM, EST
November
18, 2004, Thursday
Speaker: Mike Berkley, L.Ac., DA (RI), (Director and
Founder of The
Berkley Center for Reproductive Wellness)
Topic: East Meets West in Reproductive Health, (Acupuncture
and Herbal
Medicine)
Time: 8-9 PM, EST
December
1, 2004
Speaker: Angeline Beltsos, M.D., (Fertility Center of
Illinois)
Topic: Unexplained Infertility
Time: 8-9 PM, EST
Click
here for Connections Online
|
Welcome
to the November issue of Connections. In this issue
you will find:
Dear Friend:
Fall has
been a busy season for the AFA. We have introduced our new
name to our members and the industry, we have held our annual
fundraiser, the Kokopelli Ball, honoring the professionals
that help us to achieve our family building dreams, and we
have attended the American Society of Reproductive Medicine
(ASRM) conference to further reach-out to professionals in
the field. And that's not all. Read on to learn about seminars
on Ovum Donation and Adoption in New York City, an informational
session in New Jersey on Pathways to Pregnancy with Reproductive
Medicine Associates, as well as our first annual Golf "Fore" Kids Invitational in Palm Beach, Florida.
You will
also find in this information-packed Connections, details
on our ground-breaking relationship with the RAND
Corporation to study the health of IVF Children.
I hope
you will read on for details on all of these exciting and
informational programs and services provided by The AFA.
And, if
you haven't been to our new Web site, please visit us at www.TheAFA.org to see all the new information available including new message
boards, fact sheets and much, much more.
Stay well,
Pam
Ovum
Donation Seminar (Click here
for more information)
The
American Fertility Association is
sponsoring an Ovum Donation Seminar
Series beginning Monday, October
25, 2004 for six consecutive weeks.
Each of the six weekly seminars
will discuss in detail a different
aspect of the ovum donor process
enabling individuals to get a clear
understanding of the medical, psychological,
and practical choices that are part
of this family building option.
| Where: |
The
National Council of Jewish Women
Second Floor
820 2nd Avenue (Between E 43rd and E 44th Streets)
New York, NY |
| When: |
Mondays
7:00 PM to 9:00 PM
October 25, November 1st, 8th, 15th, 22nd and 29th |
| Cost: |
$200
per household |
Adoption
Seminar (Click here
for more information)
When you
choose to adopt you are making a lifetime decision. Find out
whether adoption is the way to build your family by exploring
the options, gathering the facts, and empowering yourself
to make the choice that is right for you.
| Where: |
The
National Council of Jewish Women
Second Floor
820 2nd Avenue (Between E 43rd and E 44th Streets)
New York, NY |
| When: |
Wednesdays
6:30 PM to 8:30 PM
November 10th, 17th, and December 1st, 8th and 15th |
| Cost:
|
$150
per household |
A new
fact sheet on adoption is also now available on our Web site
at www.TheAFA.org.
"An
Evening with Leading Infertility
Experts" - an AFA patient seminar
The American
Fertility Association (AFA) presents a very special educational
event on infertility in collaboration with Reproductive
Medicine
Associates (RMA), one of the most successful fertility clinics
nation-wide.
RMA infertility
experts Dr. Brad Miller and Dr. Doreen Hock will discuss how
to choose and evaluate a fertility specialist or clinic.
Beth
Harley, RN, will explain counseling options and educational
seminars
for patients, the emotional and physical stress infertility
can create, and
how emotional support can have a positive impact on treatment.
Drs. Miller
and Hock and Ms. Harley will all be available to answer patients'
questions.
| When: |
Wednesday, November 17, 2004
7:00 PM (6:30 PM registration) |
| Where: |
New Brunswick Hyatt
Two Albany Street, New Brunswick, NJ |
Please
contact The AFA's Lori Masi at 888-917-4777 to register.
This
patient seminar is free and parking is available. Refreshments
will be
served.
Sponsored
by Reproductive Medicine Associates and Schraft's,
A Specialty Pharmacy.
Golf
"Fore" Kids Invitational
(Click here
for more information)
It's
not too late to register for the
first annual American Fertility
Association Golf "Fore"
Kids Invitational to be
held in warm and welcoming Palm
Beach, Florida on December 5, 2004.
| Where: |
PGA
National Resort and Spa
Palm Beach Gardens, Florida |
| When: |
December
5, 2004 |
| Cost:
|
Single
Golfer's Ticket: $350 per person
(Includes breakfast, 18-holes of golf and
lunch)
Single Non-Golfer's Ticket: $100
(Includes breakfast and lunch) |
| RSVP: |
Corey
Whelan at (718) 853-1411 or via email at corey@theafa.org
For tickets and sponsorship opportunities. |
| Kokopelli
Ball 2004
Co-hosts, Olympic Gold Medal swimmer Dara
Torres and News Channel 4-NBC Medical Correspondent
Dr. Max Gomez, joined by special guest Brooke
Shields, helped to make the 2004 Kokopelli Ball
one to remember!
|
|

Brooke
Shields, Dr. Max Gomez, and Dara Torres, Masters of Ceremony
at the 2004 Kokopelli Ball |
Footprints:
The IVF Children's Health Study
The AFA
announces "Footprints: The IVF Children's Health Study," the first longitudinal, prospective, and scientifically objective
study that chronicles the health and welfare of children conceived
through IVF.
There
are at least 250,000 IVF children born in the U.S. to date.
"Footprints" will deliver facts - not hypotheses
- about the physical, emotional and intellectual development
of this significant and growing population.
"Footprints" is a partnership between The AFA and the RAND Corporation,
a nonprofit research organization providing objective analysis
and effective solutions that address the challenges facing
the public and private sectors around the world.
The AFA
and RAND Health have begun to work closely on the data collection
strategies for this innovative research endeavor. This forward-looking
study will track multiple gestations, birth weight, birth
defects, surgical procedures, physical health, and developmental
milestones for IVF children.
Serono,
Inc. has provided The AFA with an unrestricted educational
grant for "Footprints," which will serve as initial
funding to assist with the development of the study design
and the collection of pilot data from a cross-section of U.S.
IVF centers. The AFA and the RAND Corporation will seek federal
funding for "Footprints," enabling it to become
an expanded national study.
Click
here for further information on Footprints:
The IVF Children's Health Study.
|
| ULTRASOUND
AND INFERTILITY:
DIAGNOSTIC AND THERAPEUTIC USES
by Michael P. Zahalsky, M.D.and Harris M. Nagler, M.D.,
F.A.C.S
Ultrasonography
has become widely utilized as a diagnostic technique in medicine.
It allows the visualization of structures within the body
by transmitting sound waves through the skin. These high frequency
sound waves are then reflected off the surfaces of internal
structures. The same instrument that transmitted the sound
waves then receives the reflected sound waves. Computers process
the signals and an image (picture) is created. This is technology
similar to that utilized by ships to visualize the bottom
of the ocean or fisherman to identify schools of fish. This
article will describe ultrasonography in greater detail and
discuss its application to the infertile male.
Ultrasound
has become essential in the diagnosis of the infertile male.
It allows visualization of the male reproductive organs and
the male reproductive tract. The two primary types of ultrasonography
used by urologists to evaluate men are scrotal and transrectal
ultrasonography.
Scrotal ultrasonography provides a detailed examination of
the testicles, indicates the presence or absence of varicoceles,
and can identify other abnormalities. Transrectal ultrasonography
can visualize the male reproductive tract including the ejaculatory
ducts, seminal vesicles, and vas deferens. These ultrasonographic
techniques have provided the urologist with non-or minimally-invasive
techniques with which to evaluate the infertile male.
Current
estimates indicate that infertility affects approximately
15% of all couples attempting their first pregnancy. In infertile
relationships, male infertility has been found responsible
for approximately 30-40% of all cases of infertility.
Semen
analysis is the bedrock of laboratory testing in dealing with
male infertility. However, it is not highly predictive of
fertility, which is couple-related phenomenon and can only
be determined by initiation of pregnancy. Semen analysis examines
the quantity and quality of sperm present in a specimen.
ULTRASONOGRAPHY:
TECHNICAL CONSIDERATIONS
Ultrasonography is used both scrotally and transrectally in
the evaluation of male infertility in order to identify structural
abnormalities which may be the cause of abnormalities detected
by the semen analysis or abnormal findings on physical examination.
The ultrasound wave is initiated by a transducer. The
transmitted sound waves are directed to the area of interest
and interact with tissues of various densities, reflective
and absorptive characteristics and are converted into computer
generated images. The frequency of the ultrasound wave determines
the structure that can be visualized.
Ultrasound
imaging techniques include real-time ultrasound, Doppler ultrasound, and color flow Doppler imaging. The real-time
ultrasound images are produced when high-speed ultrasonic
beams create independent images at high rates. For superficial
examination of the scrotum and penis, a high-frequency probe
is optimal because it provides greater resolution of the superficial
areas of interest. A slightly lower frequency probe allowing
deeper penetration is used for transrectal ultrasonography
(TRUS). Transrectal ultrasonography is utilized to identify
abnormalities in the prostate, the seminal vesicles and ejaculatory
ducts.
Doppler
ultrasonography provides the physician with the ability to
measure directional blood flow. A pulsed Doppler system measures
flow velocity by the transmission at regular intervals of
short bursts of ultrasound waves that are reflected from a
moving target. Duplex ultrasound combines the pulsed Doppler
system with real-time imaging. This technique is extremely
valuable in the imaging of small vessels. This is the technique
that is commonly employed in the diagnosis of varicoceles.
SCROTAL
ULTRASONOGRAPHY
Scrotal contents can be accurately assessed with ultrasonography.
Testicular abnormalities, which may be identified by ultrasonography,
include: testicular tumors both benign and malignant, testicular
cysts, and testicular calcifications (microlithiasis). Additionally,
abnormalities in the scrotal contents including adnexal abnormalities
can be observed. The adnexa are the structures within the
scrotum, which are responsible for the maturation and delivery
of sperm. Spermatoceles (cysts containing sperm) and hydroceles
(fluid accumulation around the testicle) can be visualized
with scrotal ultrasonography eliminating the need for diagnostic
surgical procedures. Ultrasonography may also be used to calculate
testicular volume and texture.
Testicular tumors are, unfortunately found more frequently in infertile men than the normal population. The rate of testicular
tumors found in an infertile group of men was 1 in 200, which
is significantly higher than the 1 in 20,000 that is reported
for the general population. Although, ultrasonography is useful
in the diagnosis of testicular masses, it is not utilized
to screen all infertile men. Most testicular tumors are appreciated
by routine physical examination or because of patient symptoms.
Recently,
it has become apparent that patients with testicular microlithiasis
have an increased risk of developing testicular tumors. Therefore,
patients identified as having calcifications within the testicle
often undergo routine and periodic scrotal ultrasonography.
This entity - microlithiasis, abnormal calcifications of the
testicle - was not diagnosed until the initiation of scrotal
ultrasonography.
Testicular
torsion is an acute event associated with severe testicular
pain and swelling due to the abrupt twisting of the testicle
blocking the blood flow to the testicle. This can be accurately
diagnosed when no blood flow to the testicle is demonstrated
by color flow Doppler (CFD) ultrasonography. Patients with
testicular torsion appear to have decreased fertility. The
ability to rapidly and accurately diagnose testicular torsion
results in preservation of the testicle and, hopefully, reduced
infertility
Although
each of the above conditions may affect male fertility, scrotal
ultrasonography plays its major role in the evaluation of
the infertile male by the detection or confirmation of a varicocele,
an abnormal dilatation of the testicular venous system thought
to be the leading cause of male infertility. Real-time ultrasonography
provides a visual image of the scrotal contents and has also
been used to diagnose varicoceles13. Most urologists believe
that ultrasonography should be utilized to confirm physical
findings or resolve controversy regarding physical findings.
Scrotal ultrasonography should not be utilized to search for
varicoceles that cannot be appreciated by physical examination.
Studies have demonstrated that subclinical varicoceles are
not a cause of male factor infertility.
TRANSRECTAL
ULTRASONOGRAPHY - EVALUATION OF THE SPERM DELIVERY SYSTEM:
While vasography is the foremost tool in evaluating the normalcy
of the vas deferens and the ejaculatory duct, transrectal
ultrasonography (TRUS) has recently emerged as a significant
diagnostic tool in the evaluation of abnormalities of the
ejaculatory duct apparatus7. Initially used solely to evaluate
the prostate, TRUS has recently gained much attention in the
evaluation of male infertility. Recent improvements in transrectal
ultrasound, with the use of higher frequency multiplanar transducers,
have enabled the ejaculatory ducts to be visualized14. Ejaculatory
duct obstruction is currently recognized more frequently than
in the past due to its ability to be diagnosed by TRUS15,16.
Infertility patients presenting with a low ejaculate volume,
zero or a decreased number of sperm in the ejaculate, or significant
sperm motility abnormalities are all appropriate candidates
for TRUS. Any patient with a prior history of prostate infections,
prostatitis, and evidence of diminished seminal volume warrants
TRUS. In patients suspected of having ejaculatory duct obstruction
(EDO), TRUS, being virtually risk-free, has nearly supplanted
vasography. Detection of ejaculatory duct obstruction is important
because it is a specifically treatable, correctable cause
of male factor infertility.
CONCLUSION
Recent developments have resulted in dramatic advancement
in the diagnostic evaluation of the infertile male. By developing
highly specific imaging procedures, it has enabled more precise
targeting of the abnormalities responsible for the previously
ill-defined causes of male infertility and identifying potentially
significant medical conditions. While the standard semen analysis
maintains its position as the initial study of choice, more
advanced imaging studies can be used to pinpoint specific
abnormalities of physiologic or anatomic significance. The
rapid progress in therapeutic options for infertile couples
combined with improvements in the diagnostic arena will allow
physicians to more aggressively, more accurately, and more
successfully treat the infertile male.
|